Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRT Appoints Board Member

This article was originally published in Scrip

Executive Summary

Cancer Research Technology (CRT) has appointed Dr. Deborah Harland to its board as non-executive director. Deborah, who has held various roles in business development, clinical development and medical affairs, is currently a partner at the corporate venture capital arm of GlaxoSmithKline, SR One. She is also on the board of various biotech companies, in which SR One has invested, including Mission Therapeutics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel